1 of 1
Story summary
- Researchers at The University of Manchester find ulipristal acetate may reduce breast cancer risk in pre-menopausal women with a family history.
- The drug blocks progesterone's effects, which can promote cancerous cell growth.
- MRI scans show the treatment reduced breast tissue density, a known risk factor.
- The findings suggest women with high breast density could benefit most.
- This work lays groundwork for larger trials.
